
What happened
Sony Innovation Fund Senior Investment Director Kei Furukawa said the fund has backed roughly 220 startups worldwide through six funds, and Sony showcased five portfolio firms plus two Sony-born spinoffs at CEATEC 2026.
Why it matters
The showcase signals that Sony is using its venture arm and incubation to pull outside technology into its own businesses, and Pictoria's Picto STAND is already moving into Japanese airports.
Summaries like this, every morning.
Sony's CEATEC presence has shifted from showing its own in-house ideas to presenting a pipeline of outside companies it has backed. Last year's exhibit, themed "Beyond the Boundaries," centered on the Sony Acceleration Platform and included REON POCKET PRO from Sony's internal startup program; this year the emphasis moved to startup investment and business creation, with AI characters and microsurgery robots on display.
The structure behind that shift is the Sony Innovation Fund, set up in 2016 as Sony's corporate venture arm. Furukawa said some SIF funds include outside investors such as financial institutions and other companies, unlike conventional corporate venture funds backed only by the parent. He also stressed that Sony's aim goes beyond financial return, using collaboration with startups to reach technology and business opportunities its own teams might not have produced.
The two Sony-born companies on show illustrate the internal path. Qoly Corporation, a spinoff from Sony's incubation program, demonstrated a prototype developed about three years ago in which a 10mm console movement becomes 1mm at the instrument, with the surgeon fully in control rather than the robot acting autonomously.
Pick your industry and the AI tools you use, and get news related to your work every day.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. The AI reads this article, earlier AIToday articles, and Wikipedia, and cites its sources. Q&As are published on this page for other readers too.
S&P Global reports Q3 on Oct

Tempus AI expanded its drug development collaborations with Bristol Myers Squibb and Pathos AI

Vertiv and NVIDIA presented at GTC on how they can halve AI factory deployment time

Danaher (DHR) received FDA clearance for AI-powered atrial fibrillation detection

CVS Health appointed Jack Hanlon, who previously held senior data and analytics roles at Meta and Reddit, as s…

T-Mobile US completed what Nvidia described as the first AI-RAN call on a live commercial network, unveiled at…
